Clinical Trial Update: Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]

View source ↗

Summary

The study reports Phase 1 and Phase 2 results for chemoimmunotherapy including epratuzumab in children with relapsed acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Epratuzumab (epratuzumab)

Snippet

Sponsor: Children's Oncology Group | Conditions: Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-26